Loading company…
UK-based pharmaceutical company, formerly Atnahs Pharma, focused on life cycle management of established medicines.
Founded in 2013 and headquartered in the UK, Pharmanovia, formerly known as Atnahs Pharma, focuses on life cycle management of established medicines in areas including cardiovascular, endocrinology, neurology and oncology. Its products include Inderal, Tenormin, Anaprox, Bonviva and Synacthen, sold through partnerships and direct transactions with healthcare providers and distributors. In fiscal 2024 it reported revenue of EUR 509.84 mn and EBITDA of EUR 180.05 mn. James Burt is the current CEO, and on August 8, 2024 the company received a EUR 5 million senior term loan from CIC Private Debt.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in